Who Latitude Venture invest in
- Entrepreneurship and startup in the field of Chemistry, Life science and Medical technology (CLM)
- Entrepreneurs equipped with the cutting edge of knowledge and have a bold vision to transform humanity,
- Technology-intensive businesses with the potential for exponential growth.
- Start-ups that are technologically inimitable, where technological barriers are the source of a premium.
- Emerging Technology Startups have been identified & invited by the Bio Pro Association Panel.
Why invest in knowledge-building stage business
- Rather than waiting for companies to come to us, we use our global network of Bio Pro Association members and industry insiders to invite emerging companies to grow with us.
- With a unique ability to anticipate sector trends, our panel of senior industry experts and academics focus on first selecting tracks and then investing in specific targets.
- Distinctive premium
The earlier the investment, the greater the return, especially when startups need the investment most.
- Unmatched funding efficiency
We invest in the most valuable asset - core technology development - which is the fastest value-creating phase of a CLM start-up.
By investing in the early stages of a company's business development, we have much more opportunity to manage investment risk in many aspects such as business organisation, operational management, regulatory framework, financial transparency, etc. in advance (educating and guiding the company on risk control).
- By using the CLM facility platform, we can also monitor the investment and obtain first-hand information such as the development process of the targets, the use of funds and the organisation of the business structure, resulting in the best risk management for the investment.
- Best growth motive,
Motive is the key to success in business and entrepreneurship. our investment pattern garnetted we always invest in the top talent with sufficient knowledge preparation, at their most energetic and ambiguous age.
The venture acts as a professional private equity firm and is not driven by probability like VCs. As industry insiders in the CLM sector, we can improve the business of our portfolio companies in ways other than just injecting money; we can bring unique knowledge and sector-specific resources that ordinary investors don't have.
How the venture invests
- for CLM facility members who joined during the R&D phase.We invest in the form of waivers on lab usage and consumed regent & consumables, and the long-term hired consultant cost on technology troubleshooting. We will monitor the development process, and acceptable & successful companies will enter the next phase of investment, on their choice.
- We provide initial funding, typically $250K, or $500K, to CLM facility members with a invitation from Bio Pro Association or whose investment request has passed the Bio Pro Association panel review.
- We lead-invest with our investment partners in seed rounds for companies that have already received initial funding from Latitude Venture, typically $1~5M.
- We also provide essential business resources required by the start-ups to scale up their business, including supply chain, expert workforce and manufacturing capacity; these resource services are considered in-kind capital injections and are priced on a case-by-case basis.
How the venture exists
The venture offer equity exits options for investees:
- Buyback at the pre-agreed price & timetable.
- Exit at the pre-agreed stage of fundraising.
The venture may also decide to take and hold the equity permanently for strategic purposes and will only exit if the venture is terminated.
What makes Latitude Venture unique?
- We have a panel of senior academics and industry experts from the Bio Pro Association, with a convincing ability to assess the feasibility of any technology and the ability to anticipate industry trends.
- The venture has competent scholar and expert in the field of CLM, with sufficient knowledge & experience in a given specific field, who is eligible to act as a supervisor of Ph.D. candidates, which is indispensable to forming a higher degree scholarship or CRC with universities.
- To invest knowledge successfully, investors need knowledge preparation, the best is an insider with vertical sector resources and connections at hand. Which made the venture invest like a private equity.
- The venture’s existing business can be a synergy and cooperation with the investee's business.
Who has now invested through the venture?
Holocyte Pty Ltd/ GMES, as sector insiders, invest with their own funds.
The venture is open to whom to make investments.
- BPA members, mostly university scholars & industry experts in the CLM field
- Venture partners, best business owners and insiders in the field of CLM
Portfolio
Latitude Venture is a newly built Venture, we don’t have investment records by now.
Whilst we prepared several spinoff companies from Holocyte and GAMES to act as trial examples of the venture's investment model.
The model companies' fund injection has been and will be fully made by Holocyte and will be fully incubated by the CLM Facility platform & Latitude Venture. we keep their operational records transparent to BPA members Venture partners and pre-agreed external parties, to build CLM Facility platform & Latitude Venture's reputation.